The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The antidiabetics market has experienced rapid growth in recent years, increasing from $68.32 billion in 2023 to $76.03 billion in 2024, with a compound annual growth rate (CAGR) of 11.3%. Key factors driving this growth include the rising global prevalence of diabetes, advancements in drug development, increased awareness and diagnosis, supportive government policies, a growing geriatric population, and the rise of sedentary lifestyles. The antidiabetics market is expected to continue its expansion, reaching $117.04 billion by 2028, with a CAGR of 11.4%. This forecasted growth is driven by the increasing prevalence of diabetes, greater awareness and diagnosis rates, rising healthcare expenditure, expanding geriatric populations, and government initiatives and health policies. Major trends in the forecast period include the growth of GLP-1 receptor agonists, SGLT2 inhibitors, biologics, biosimilars, a focus on preventive healthcare, emerging market expansion, and technological integration.

The rising incidence of lifestyle-related conditions is expected to propel the growth of the antidiabetics market going forward. Lifestyle-related conditions are health issues caused or exacerbated by behaviors such as poor diet, lack of exercise, smoking, and excessive alcohol consumption. The incidence of lifestyle-related conditions is growing due to poor diet, physical inactivity, and increased stress levels. Antidiabetic medications can help manage lifestyle-related conditions like obesity and metabolic syndrome by improving insulin sensitivity and controlling blood sugar levels. For instance, in March 2022, the World Health Organization, a Switzerland-based intergovernmental organization, reported that around 1 billion people worldwide, 650 million adults, 340 million teenagers, and 39 million children, were obese. This number continues to rise. By 2025, an estimated 167 million adults and children will suffer health consequences due to being overweight or obese. Therefore, a rising incidence of lifestyle-related conditions is driving the antidiabetics market, with continued growth expected through 2024 and into 2028.

Get A Free Sample On The Antidiabetics Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18225&type=smp

What Are The Key Trends That Influence Antidiabetics Market Share Analysis?

Major companies operating in the antidiabetics market are developing advanced products, such as the anti-diabetic biosimilar, to improve glycemic control, reduce the risk of cardiovascular events, and offer more effective treatment options for individuals with diabetes. An anti-diabetic biosimilar is a biologically similar medication to an already approved reference drug used to treat diabetes, offering comparable safety, effectiveness, and quality. For instance, in January 2024, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched the first biosimilar of Liraglutide, an anti-diabetic drug. The biosimilar of the Liraglutide anti-diabetic drug, launched as Lirafit, improves glycemic control in adults with type 2 diabetes mellitus. Clinical trials have shown it lowers glycemic parameters, aids in weight loss, and enhances cardiovascular safety. As a GLP-1 receptor agonist, it boosts glucose-dependent insulin secretion and reduces inappropriate glucagon secretion. It is globally approved for managing type 2 diabetes in adults.

How Is The Global Antidiabetics Market Segmented?

1) By Drug Class: Insulin; GLP-1 Receptor Agonists; DPP- 4 Inhibitors; SGLT2 Inhibitors; Other Drug Classes,
2) By Diabetes Type: Type 1; Type 2
3) By Patient Population: Antidiabetics For Pediatrics; Antidiabetics For Adults; Antidiabetics For Geriatrics
4) By Route Of Administration: Antidiabetics Administration Through Insulin Syringes Or Insulin Pens; Antidiabetics Administration Through Insulin Pumps; Intravenous Antidiabetics Infusion; Oral Antidiabetics Administration; Other Routes Of Antidiabetics Administration
5) By Distribution Channel: Online Pharmacies; Hospital Pharmacies; Retail Pharmacies

Read The Full Antidiabetics Market Report Here:

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

The Antidiabetics Global Market Report 2024 provides an overview of the antidiabetics market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The antidiabetics market forecast analyzes antidiabetics market size, antidiabetics market share, leading competitor and their market positions.

The Table Of Content For The Antidiabetics Market Include:

Explore Similar Reports From The Business Research Company:

Diabetic Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foods-global-market-report

Diabetic Foot Ulcer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-global-market-report

Diabetic Foot Ulcer Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: